Pharma Focus Asia
Eppendorf Bioprocess Solutions

Newly Engineered Cas9 Now Allows Isolated Gene-editing

Genetic engineers and researchers alike have explicitly shared their affinity towards the gene-editing tool called CRISPR–Cas9. This device alters targeted genes effortlessly, thereby permitting an executable approach to developing treatments and cures. There is, however, a major limitation to Cas9 in terms of rectifying an isolated DNA letter in a gene.

 

 
Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACPHI Korea 2023Bora Pharmaceutical - A robust approach to analytical testing is essentialSelangor International Expo MEDIC 2023TFS - Webinar - DynaSpin™ Single-Use Centrifuge for harvest applicationsMedical Fair Thailand 2023ThermoFisher Scientific - NEW Mobile AppCPHI & PMEC China 20233rd ANNUAL COMPUTER SOFTWARE ASSURANCE 2023Pharma Regulatory Conclave 202320th Anniversary Hospitalog Asia 2023
Charles River Laboratories - Endosafe Compendial LAL Cartridge Technology